Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer


12th World Cancer Conference

London, UK

Murugan Avaniyapuram Kannan

Murugan Avaniyapuram Kannan

King Faisal Specialist Hospital and Research Center, Saudi Arabia


Murugan Avaniyapuram Kannan completed his PhD from the Dept. of Molecular Oncology, Tokyo Medical and Dental University, Tokyo, Japan and postdoctoral studies from Hoshi University, Tokyo, Japan and The Johns Hopkins University School of Medicine, Baltimore, USA. Currently, he is a Scientist in the Dept. of Molecular Oncology, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia. He has published more than 30 papers in reputed journals and holding a patent for identification of novel ALK mutations in anaplastic thyroid cancer. His research focuses on molecular biology of head and neck squamous cell carcinoma and thyroid cancer identifying molecular therapeutic targets and biomarkers. He has been serving as reviewer in thyroid, PLOS One, Cancer Research, Tumor Biology, Endocrine Related Cancer, Oral Oncology


Abstract : Frequent V600E and other Non-hotspot BRAF Mutations in Adult Differentiated Thyroid Cancer